Latest News
The wages of American workers are under pressure. AI's potential role is drawing more attention
Wage growth for workers has slowed and is struggling to keep pace with inflation. It is too soon to say whether AI is contributing to slower wage growth or putting pressure on workers' pay.
Mako Mining: Record Gold Sales, Lower Profits, And I'm Still Buying
Mako Mining is rated Buy with a $13.00 target, offering 27.7% upside based on 0.95x NAV. MAKO's thesis centers on owning two producing mines and two advanced projects, all without share dilution or ne
AI's Growing Debt Appetite: Why This Time May Be Different
Key Takeaways USD investment-grade bond issuance has topped $1.5 trillion in 2026, with 20 jumbo deals worth $384 billion driving much of the pace. Technology companies have accounted for roughly 60%
Nasdaq's $100 Million Kraken Bet Prepares It for a Market That Never Closes
Nasdaq TodayNDAQNasdaq$91.19 -0.82 (-0.89%) As of 09/11/2026 04:00 PM Eastern52-Week Range$76.55▼$101.79Dividend Yield1.36%P/E Ratio26.59Price Target$110.30Add to WatchlistAre traditional financial ex
NSJ Gold Corp. (NSJ) (9PZ) Announces Closing of Over-Subscribed Financing for Exploration and Development on its Antimony 2.0 Property, New Brunswick, Canada
Vancouver, British Columbia--(Newsfile Corp. - September 13, 2026) - NSJ Gold Corp. (CSE: NSJ) (FSE: 9PZ) (the "Company" or "NSJ")
Trip.com Q2 Earnings Preview: Regulatory Penalty Creates A Buying Opportunity (Upgrade)
Trip.com Group faces significant short-term headwinds from a RMB 3.5B antitrust fine and RMB 1.6B confiscation, impacting Q2 results. Regulatory changes require TCOM to remove exclusivity with hotels
FEPI: Providing A 25% Yield During A Broadening AI Rally
REX FANG & Innovation Equity Premium Income ETF is rated Hold, reflecting its high cash distributions but capped upside and elevated risk profile. FEPI's covered call strategy provides income but fail
CareTrust REIT: The Rent Keeps Going, And So Does The Growth
CareTrust REIT demonstrates robust FFO-per-share growth, raised 2026 guidance, and aggressive investment activity, supporting a Buy rating despite premium valuation. Q2 2026 results show normalized FF
Nvidia to pay dividends in less than 3 weeks; Here's how much 100m NVDA shares will earn
Semiconductor giant Nvidia (NASDAQ: NVDA) is set to distribute its next quarterly dividend on October 1, 2026, less than three weeks from now.
Nvidia to pay dividends in less than 3 weeks; Here's how much 100 NVDA shares will earn
Semiconductor giant Nvidia (NASDAQ: NVDA) is set to distribute its next quarterly dividend on October 1, 2026, less than three weeks from now.
SolarEdge Targets $2.4B by 2029, Bets on AI Data Center Power Growth
SolarEdge Technologies NASDAQ: SEDG outlined plans to expand its residential and commercial solar business while pursuing a new power-conversion opportunity in artificial intelligence data centers, ta
Net Lease REITs: Diversification Or Diworsification?
Essential Properties Realty Trust offers a compelling blend of diversification, income, safety, and growth, with its largest tenant at just 3.1% of base rent. Diversification reduces tenant-specific r
Rackspace Technology Deadline: RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit
NEW YORK, Sept. 13, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rackspace Technology, Inc. (NASDAQ: RXT) between May 7, 2026 and July 8,
Top Wall Street analysts recommend these 3 dividend stocks for higher returns
The ratings of these experts are backed by in-depth research of a company's financials, and thorough analysis of the factors affecting business performance.
DKS Investors Have Opportunity to Lead DICK'S Sporting Goods, Inc. Securities Fraud Lawsuit
NEW YORK, Sept. 13, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of DICK'S Sporting Goods, Inc.
Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants
LISRAYA's recent approval gives ROIV a nice commercial foundation, while additional indications could turn brepocitinib into a broader immunology franchise. ROIV's pulmonary asset with mosliciguat is
If I Were Retiring In 2032, This Is What I'd Own
Social Security faces a projected 22% benefit cut by 2032, requiring a 30%+ increase in personal retirement contributions for average Americans. I advocate a diversified, income-focused portfolio with
Everyone Is Avoiding These REITs: That's The Opportunity
Some of the most hated REIT sectors may offer the biggest upside. European REITs trade at unusually steep NAV discounts. Life science and tower REITs could recover as sentiment turns.
Seagate Technology Sees AI Storage Demand Fueling HAMR Growth and Margin Gains
Seagate Technology NASDAQ: STX CFO Gianluca Romano said demand for mass storage is being supported by the early stages of artificial intelligence infrastructure investment, with growth extending from
SpaceX: Taking Flight And Defying Lock-Ups Ahead Of Q4, Communacopia Takeaways
SpaceX is reiterated as a buy, with shares resilient despite volatility and ongoing lock-up expirations. Q2 results showed revenue up 90% to $7.8B and a reduced net loss, with aggressive AI expansion